Uniphos Enterprises (UNIENTER)₹94.94−1.80%Trading - Chemicals
In the Mar 2026 quarter (standalone), Uniphos Enterprises reported sales of ₹26.04 Cr, down 64.1% from Mar 2025, and net profit of −₹0.71 Cr. For the year to Mar 2026, sales were ₹31.88 Cr and net profit ₹21.02 Cr.
Company filings, standalone accounts; latest reported quarter Mar 2026
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.00 | 0.00 | 0.00 | 50.43 | 3.02 | 30.37 | 5.08 | 72.61 | 5.84 | 0.00 | 0.00 | 26.04 |
| Expenses | 0.78 | 0.74 | 0.68 | 51.45 | 3.77 | 30.92 | 6.09 | 74.42 | 6.69 | 1.09 | 0.96 | 26.92 |
| Operating Profit | −0.80 | −0.76 | −0.70 | −0.87 | −0.76 | −0.49 | −1.01 | −1.61 | −0.85 | −1.11 | −0.98 | −0.83 |
| OPM % | — | — | — | −1.7% | −24.7% | −1.6% | −19.6% | −2.2% | −14.3% | — | — | −3.1% |
| Other Income | 0.92 | 40.58 | 0.88 | 0.66 | 0.80 | 4.69 | 0.46 | 0.22 | 0.28 | 24.53 | 0.14 | 0.41 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.13 | 1.16 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.22 | 0.22 | 0.22 | 0.22 | 0.20 | 0.20 | 0.20 | 0.20 | 0.18 | 0.18 | 0.18 | 0.18 |
| Profit before tax | −0.10 | 39.63 | −0.04 | −0.43 | −0.16 | 3.87 | −1.92 | −1.59 | −0.75 | 23.23 | −1.02 | −0.60 |
| Tax % | 0.0% | 0.3% | 0.0% | 50.0% | 0.0% | 0.0% | −2.6% | 0.0% | 0.0% | 0.0% | 0.0% | 18.7% |
| Net Profit | −0.09 | 39.42 | −0.04 | −0.64 | −0.16 | 3.87 | −1.87 | −1.59 | −0.75 | 23.20 | −1.02 | −0.71 |
| EPS (Rs) | −0.02 | 5.68 | 0.00 | −0.10 | −0.03 | 0.57 | −0.28 | −0.24 | −0.12 | 3.34 | −0.16 | −0.11 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.99 | 0.99 | 0.99 | 50.78 | 112 | 31.88 | 31.88 |
| Expenses | 0.99 | 1.99 | 1.99 | 2.99 | 1.99 | 3.99 | 3.99 | 3.99 | 53.94 | 115 | 35.94 | 35.66 |
| Operating Profit | −1.01 | −2.01 | −2.01 | −3.01 | −2.01 | −3.01 | −3.01 | −3.01 | −3.01 | −4.01 | −4.01 | −3.77 |
| OPM % | — | — | — | — | −987.0% | −370.0% | −257.0% | −195.0% | −6.0% | −3.4% | −12.0% | −11.8% |
| Other Income | 14.06 | 13.05 | 20.09 | 24.07 | 23.09 | 26.09 | 57.23 | 43.14 | 43.16 | 6.02 | 25.10 | 25.36 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.99 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.01 | 1.01 | 1.01 | 1.01 | 0.72 |
| Profit before tax | 12.05 | 11.04 | 18.06 | 21.06 | 20.08 | 23.08 | 54.22 | 40.17 | 39.15 | 0.00 | 21.08 | 20.86 |
| Tax % | 0.0% | 0.0% | 2.0% | 2.0% | 2.0% | −4.0% | −1.0% | 1.0% | 1.0% | −22.0% | 1.0% | — |
| Exceptional items | 0.00 | 0.00 | 0.99 | 0.99 | −0.99 | 0.99 | 0.99 | 0.99 | 0.99 | 0.00 | 0.00 | — |
| Net Profit | 12.01 | 11.01 | 18.01 | 21.02 | 20.03 | 24.02 | 55.07 | 39.05 | 39.04 | 0.00 | 21.02 | 20.72 |
| EPS (Rs) | 1.71 | 1.63 | 2.55 | 3.00 | 2.90 | 3.53 | 7.87 | 5.65 | 5.56 | 0.05 | 2.99 | 2.95 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 97.1% | 72.1% | 115.1% | 103.1% | 1,242.1% | 118.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 14.03 | 14.03 | 14.00 | 13.99 | 14.00 | 14.01 | 13.99 | 14.00 | 14.00 | 14.00 | 13.99 | 13.99 |
| Reserves | 258 | 271 | 2,049 | 2,072 | 2,680 | 1,503 | 2,695 | 3,162 | 2,980 | 2,059 | 2,725 | 2,427 |
| Borrowings | 10.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.01 | 57.27 | 122 | 98.47 | 2.01 | 100 | 173 |
| Total Liabilities | 282 | 285 | 2,063 | 2,086 | 2,694 | 1,518 | 2,766 | 3,298 | 3,091 | 2,075 | 2,840 | 2,614 |
| Fixed Assets | 175 | 175 | 176 | 175 | 176 | 175 | 177 | 177 | 185 | 183 | 183 | 183 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 83.85 | 83.81 | 1,852 | 1,867 | 2,478 | 1,259 | 2,543 | 3,075 | 2,852 | 1,798 | 2,613 | 2,366 |
| Other Assets | 24.08 | 26.08 | 36.13 | 44.14 | 40.16 | 83.26 | 46.15 | 46.15 | 55.21 | 92.30 | 44.16 | 65.29 |
| Trade receivables | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.49 | 0.00 | 26.22 |
| Cash & equivalents | 2.23 | 2.87 | 1.00 | 6.35 | 1.23 | 42.79 | 4.33 | 6.75 | 32.01 | 47.52 | 16.08 | 15.84 |
| Total Assets | 282 | 285 | 2,063 | 2,086 | 2,694 | 1,518 | 2,766 | 3,298 | 3,091 | 2,075 | 2,840 | 2,614 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | −7.98 | −1.99 | −1.99 | −2.99 | −2.99 | −1.99 | −4.98 | 0.99 | −0.99 | −2.99 | −2.99 | −2.99 |
| Cash from investing activity | 9.97 | 13.96 | 0.00 | 8.98 | −1.99 | 43.89 | −33.92 | 19.97 | 40.93 | 49.85 | 52.84 | 9.97 |
| Cash from financing activity | −1.01 | −11.04 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | −24.06 | −39.11 | −45.11 | −41.11 | −3.01 |
| Net cash flow | 1.01 | 1.01 | −2.01 | 5.02 | −5.01 | 42.15 | −38.11 | −3.01 | 0.00 | 1.01 | 9.03 | 3.01 |
| Capex | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free cash flow | −8.02 | −2.01 | −2.01 | −3.01 | −3.01 | −2.01 | −5.02 | 1.01 | −1.01 | −3.01 | −3.01 | −3.01 |
| CFO / OP % | 870.0% | 93.0% | 105.0% | 109.0% | 93.0% | 77.0% | 117.0% | 91.0% | 90.0% | 90.0% | 66.0% | 87.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 0 | — | — | — | — | 0 | 0 | 0 | 0 | 2 | 0 | 297 |
| Inventory days | 0 | — | — | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash conversion cycle | 0 | — | — | — | — | 0 | 0 | 0 | 0 | 3 | 0 | 298 |
| Working capital days | −1,983 | — | — | — | — | 24,771 | 6,679 | 4,433 | 16 | −12 | −7 | −22 |
| ROCE % | 3.0% | 4.0% | 1.0% | 1.0% | 1.0% | 1.0% | 1.0% | 2.0% | 1.0% | 1.0% | 0.0% | 1.0% |
For the Mar 2026 quarter, Uniphos Enterprises reported sales of ₹26.04 Cr, down 64.1% year on year and net profit of −₹0.71 Cr. The operating margin was −3.1%.
Uniphos Enterprises' sales for the year to Mar 2026 were ₹31.88 Cr; over the last twelve months they were ₹31.88 Cr.
Net profit for the year to Mar 2026 was ₹21.02 Cr, and ₹20.72 Cr over the last twelve months. Earnings per share over the same trailing period were ₹2.95.
Uniphos Enterprises reported borrowings of ₹0 Cr at Mar 2026, against cash and equivalents of ₹15.84 Cr.
Cash from operations was −₹2.99 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹3.01 Cr.